These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30898592)

  • 21. A comprehensive review of metabolic syndrome affecting erectile dysfunction.
    Kaya E; Sikka SC; Gur S
    J Sex Med; 2015 Apr; 12(4):856-75. PubMed ID: 25675988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones.
    Arefhosseini S; Ebrahimi-Mameghani M; Najafipour F; Tutunchi H
    Front Endocrinol (Lausanne); 2022; 13():1032361. PubMed ID: 36419770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semen quality impairment is associated with sexual dysfunction according to its severity.
    Lotti F; Corona G; Castellini G; Maseroli E; Fino MG; Cozzolino M; Maggi M
    Hum Reprod; 2016 Dec; 31(12):2668-2680. PubMed ID: 27733531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM; Patel A; Bownik H; Oranu A; Kerner C; Praestgaard A; Forde KA; Reddy KR; Lichtenstein GR
    Dig Dis Sci; 2017 May; 62(5):1354-1361. PubMed ID: 28265826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogonadism and non-alcoholic fatty liver disease.
    Mintziori G; Poulakos P; Tsametis C; Goulis DG
    Minerva Endocrinol; 2017 Jun; 42(2):145-150. PubMed ID: 27879963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
    Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
    Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet and Men's Sexual Health.
    La J; Roberts NH; Yafi FA
    Sex Med Rev; 2018 Jan; 6(1):54-68. PubMed ID: 28778698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review.
    Stahl EP; Dhindsa DS; Lee SK; Sandesara PB; Chalasani NP; Sperling LS
    J Am Coll Cardiol; 2019 Mar; 73(8):948-963. PubMed ID: 30819364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S; Taskinen MR; Borén J
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inter-relational effect of metabolic syndrome and sexual dysfunction on hypogonadism in type II diabetic men.
    Amidu N; Owiredu WKBA; Gyasi-Sarpong CK; Alidu H; Antuamwine BB; Sarpong C
    Int J Impot Res; 2017 May; 29(3):120-125. PubMed ID: 28275230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common features of the metabolic syndrome and nonalcoholic fatty liver disease.
    Almeda-Valdes P; Aguilar-Olivos N; Uribe M; Méndez-Sánchez N
    Rev Recent Clin Trials; 2014; 9(3):148-58. PubMed ID: 25514910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and sexual dysfunction.
    Schulster ML; Liang SE; Najari BB
    Curr Opin Urol; 2017 Sep; 27(5):435-440. PubMed ID: 28650864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.